The Effect of Virtual Reality and Music in High-Risk Pregnants on Non-Stress Test

May 10, 2023 updated by: NESLİHAN YILMAZ SEZER

The Effect of Virtual Reality and Music Application on Non-Stress Test Parameters, Anxiety and Satisfaction During Non-Stress Test in High-Risk Pregnants

Aim: The aim of this study is to determine the effects of virtual reality and listening to music during the NST procedure on NST parameters, anxiety and satisfaction in high-risk pregnant.

Hypotheses H01 In the NST process, there is no difference between the NST parameters of the virtual reality group and the NST parameters of the control group.

H02 In the NST procedure, there was no difference between the anxiety score of the virtual reality group and the anxiety score of the control group.

H03 There is no difference between the satisfaction score of the group in which virtual reality was applied in the NST procedure and the satisfaction score of the control group.

H04 In the NST process, there is no difference between the NST parameters of the group to which the virtual reality is applied and the NST parameters of the musical group.

H05 In the NST procedure, there was no difference between the anxiety score of the group in which virtual reality was applied and the anxiety score of the music group.

H06 In the NST process, there is no difference between the satisfaction score of the group to which the virtual reality was applied and the satisfaction score of the music group.

H07 In NST operation, there is no difference between the NST parameters of the music group and the NST parameters of the control group.

H08 In the NST procedure, there was no difference between the anxiety score of the music group and the anxiety score of the control group.

H09 There is no difference between the satisfaction score of the music group and the satisfaction score of the control group in the NST procedure.

Study Overview

Status

Completed

Conditions

Detailed Description

The study will be carried out in three different groups. The practice will start with meeting the high-risk pregnant who apply to the NST. After the women are evaluated in terms of eligibility criteria for the research, the high-risk pregnant who are eligible will be informed about the research and written informed consent will be obtained from the high-risk pregnant who accept. The random distribution of high-risk pregnant to the study groups will be carried out using the Block Randomization method. The following applications will be made to the groups.

Virtual Reality Group In addition to the routine procedure, virtual reality glasses will be applied to the high-risk pregnant in the virtual reality group of the research. Virtual reality glasses is a device that works on compatible smart mobile phones. After the NST device is connected and, the high-risk pregnant included in the experimental group will be made to watch a video lasting an average of 40 minutes with virtual reality glasses until the procedure is completed.

Music Group In addition to the routine procedure, the high-risk pregnant women in the music group of the research will listen to the relaxing music used in the virtual reality application with headphones.

Control Group The high-risk pregnants in the control group of the study will not be subjected to any treatment other than the routine procedure.

Study Type

Interventional

Enrollment (Actual)

102

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey
        • Neslihan Yılmaz Sezer

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Being at the 32nd and above gestational week
  • Pregnant women with a single fetus
  • Have eaten at least two hours before the NST procedure
  • No cardiovascular disease diagnosed in the fetus,
  • The participants ate at least 2 h before the NST, urinated immediately before the NST and did not smoke or drink alcohol for at least 2 h before the NST.
  • Those diagnosed with high-risk pregnancy by a physician (pregnancy-induced hypertension, preeclampsia, eclampsia, gestational diabetes, premature rupture of membranes, pregnancy large or small for gestational age, intrauterine growth retardation, polihydramnios, oligohydramnios, premature birth threat, maternal age 35 age and above, maternal body mass index over 30 (obesity)
  • Not having vision and hearing problems

Exclusion Criteria:

  • Pregnant women with major medical (cardiac, renal or neurological diseases) or mental illnesses (psychosis, neurosis, addictions, etc.)
  • healty pregnant women
  • multiple pregnancy
  • having a fetus with anomaly,
  • Pregnant women with fetal distress and for whom emergency intervention is considered by the physician

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Virtual Reality Group
In addition to the routine procedure, virtual reality glasses will be applied to the high-risk pregnant in the virtual reality group of the research. Virtual reality glasses is a device that works on compatible smart mobile phones. After the NST device is connected and, the high-risk pregnant included in the experimental group will be made to watch a video lasting an average of 40 minutes with virtual reality glasses until the procedure is completed.
A relaxing video will be watched with virtual reality glasses.
Experimental: Music Group
In addition to the routine procedure, the high-risk pregnant women in the music group of the research will listen to the relaxing music used in the virtual reality application with headphones.
Relaxing music will be played by wearing headphones.
No Intervention: Control Group
The high-risk pregnants in the control group of the study will not be subjected to any treatment other than the routine procedure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in anxiety
Time Frame: immediately before the NST procedure and immediately after the NST procedure
STAI-S consist of 20 items with four points Likert scales, each (not at all, somewhat, moderately so, very much so). Scores thus range between 20, indicating a low level of anxiety and 80, indicating a high level.
immediately before the NST procedure and immediately after the NST procedure
the degree of satisfaction
Time Frame: immediately after the NST procedure
VAS is a 10-cm-long measurement tool. The left end of the scale reads "I am not satisfied at all" and the right end reads "very satisfied". A high score on the scale indicated a high level of satisfied and a score of 0 pointed to no satisfied.
immediately after the NST procedure
Non-Stress Test Parameters/ basal fetal heart rate
Time Frame: immediately after the NST procedure
It is the average fetal heart rate sustained over a 10-minute period and 120-160 beats/minute is normal.
immediately after the NST procedure
Non-Stress Test Parameters: number of accelerations
Time Frame: immediately after the NST procedure
Acceleration an increase in fetal heart rate.
immediately after the NST procedure
Non-Stress Test Parameters/ number of decelerations
Time Frame: immediately after the NST procedure
Deceleration is the slowing of fetal heart rate seen on the monitor during contractions.
immediately after the NST procedure
Non-Stress Test Parameters/ reactive nst
Time Frame: immediately after the NST procedure
Reactive NST; It is a normal result showing that accelerations occur at least twice within a maximum of 20 minutes, are at least 15 beats/min more than the basal level and continue for 15 seconds.
immediately after the NST procedure
Non-Stress Test Parameters / Test time (minutes) for reactive NST
Time Frame: immediately after the NST procedure
Time until reactive NST result is obtained.
immediately after the NST procedure
Non-Stress Test Parameters / Non-reaktif NST
Time Frame: immediately after the NST procedure
Non-reactive NST; An abnormal result showing that less than two of the accelerations that are at least 15 beats/min above baseline occur in a 40 min time frame.
immediately after the NST procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: AYKAN YÜCEL, Prof.Dr., Ankara Bilkent City Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 9, 2023

Primary Completion (Actual)

February 10, 2023

Study Completion (Actual)

February 10, 2023

Study Registration Dates

First Submitted

August 9, 2022

First Submitted That Met QC Criteria

August 9, 2022

First Posted (Actual)

August 10, 2022

Study Record Updates

Last Update Posted (Actual)

May 12, 2023

Last Update Submitted That Met QC Criteria

May 10, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 12/125

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on High Risk Pregnancy

Clinical Trials on Virtual Reality

Subscribe